Page 720 - Hematology_ Basic Principles and Practice ( PDFDrive )
P. 720
Chapter 42 Sickle Cell Disease 607.e5
200. Buchanan GR, Glader BE: Benign course of extreme hyperbilirubine- 227. Koshy M, Entsuah R, Koranda A, et al: Leg ulcers in patients with sickle
mia in sickle cell anemia: analysis of six cases. J Pediatr 91:21, 1977. cell disease. Blood 74:1403, 1989.
201. Kindscher JD, Laurin J, Delcore R, et al: Liver transplantation in a 228. Cackovic M, Chung C, Bolton LL, et al: Leg ulceration in the sickle
patient with sickle cell anemia. Transplantation 60:762, 1995. cell patient. J Am Coll Surg 187:307, 1998.
202. Swaim MW, Agarwal S, Rosse WF: Successful treatment of hepatitis C 229. Koshy M, Entsuah R, Koranda A, et al: Leg ulcers in patients with sickle
in sickle-cell disease. Ann Intern Med 133:750, 2000. cell disease. Blood 74:1403, 1989.
203. Koshy M: Sickle cell disease and pregnancy. Blood Rev 9:157, 1995. 230. Schleucher R, Gaessler M, Knobloch J: Rapid healing of a late diagnosed
204. Hassell K: Pregnancy and sickle cell disease. Hematol Oncol Clin North sickle cell leg ulcer using a new combination of treatment methods.
Am 19:903, 2005. J Wound Care 16:197, 2007.
205. Manchikanti A, Grimes DA, Lopez LM, et al: Steroid hormones for 231. Keidan AJ, Stuart J: Rheological effects of bed rest in sickle cell disease.
contraception in women with sickle cell disease. Cochrane Database Syst J Clin Pathol 40:1187, 1987.
Rev (2):CD006261, 2007. 232. Sher GD, Olivieri NF: Rapid healing of chronic leg ulcers during
206. Molitierno JA, Jr, Carson CC, III: Urologic manifestations of hema- arginine butyrate therapy in patients with sickle cell disease and thalas-
tologic disease sickle cell, leukemia, and thromboembolic disease. Urol semia. Blood 84:2378, 1994.
Clin North Am 30:49, 2003. 233. Covitz W, Espeland M, Gallagher D, et al: The heart in sickle cell
207. Abbott KC, Hypolite IO, Agodoa LY: Sickle cell nephropathy at end- anemia. The Cooperative Study of Sickle Cell Disease (CSSCD). Chest
stage renal disease in the United States: patient characteristics and 108:1214, 1995.
survival. Clin Nephrol 58:9, 2002. 234. Miller DM, Winslow RM, Klein HG, et al: Improved exercise perfor-
208. Perneger TV, Whelton PK, Klag MJ: Risk of kidney failure associated mance after exchange transfusion in subjects with sickle cell anemia.
with the use of acetaminophen, aspirin, and nonsteroidal antiinflam- Blood 56:1127, 1980.
matory drugs. N Engl J Med 331:1675, 1994. 235. Martin CR, Johnson CS, Cobb C, et al: Myocardial infarction in sickle
209. Powars DR, Elliott-Mills DD, Chan L, et al: Chronic renal failure in cell disease. J Natl Med Assoc 88:428, 1996.
sickle cell disease: risk factors, clinical course, and mortality. Ann Intern 236. Romero Mestre JC, Hernandez A, Agramonte O, et al: Cardiovascular
Med 115:614, 1991. autonomic dysfunction in sickle cell anemia: a possible risk factor for
210. Pariser S, Katz A: Treatment of sickle cell trait hematuria with oral urea. sudden death? Clin Auton Res 7:121, 1997.
J Urol 151:401, 1994. 237. Hassell KL, Eckman JR, Lane PA: Acute multiorgan failure syndrome: a
211. Falk RJ, Scheinman J, Phillips G, et al: Prevalence and pathologic potentially catastrophic complication of severe sickle cell pain episodes.
features of sickle cell nephropathy and response to inhibition of Am J Med 96:155, 1994.
angiotensin-converting enzyme. N Engl J Med 326:910, 1992. 238. Kumar S, Powars D, Allen J, et al: Anxiety, self-concept, and personal
212. Foucan L, Bourhis V, Bangou J, et al: A randomized trial of captopril and social adjustments in children with sickle cell anemia. J Pediatr
for microalbuminuria in normotensive adults with sickle cell anemia. 88:859, 1976.
Am J Med 104:339, 1998. 239. Vichinsky EP, Johnson R, Lubin BH: Multidisciplinary approach to
213. Batlle D, Itsarayoungyuen K, Arruda JA, et al: Hyperkalemic hyper- pain management in sickle cell disease. Am J Pediatr Hematol Oncol
chloremic metabolic acidosis in sickle cell hemoglobinopathies. Am J 4:328, 1982.
Med 72:188, 1982. 240. Platt OS, Rosenstock W, Espeland MA: Influence of sickle hemoglo-
214. Davis CJ, Jr, Mostofi FK, Sesterhenn IA: Renal medullary carcinoma. binopathies on growth and development. N Engl J Med 311:7, 1984.
The seventh sickle cell nephropathy. Am J Surg Pathol 19:1, 1995. 241. Hankins JS, Ware RE, Rogers ZR, et al: Long-term hydroxyurea
215. Adeyoju AB, Olujohungbe AB, Morris J, et al: Priapism in sickle-cell therapy for infants with sickle cell anemia: the HUSOFT extension
disease; incidence, risk factors and complications—An international study. Blood 106:2269, 2005.
multicentre study. BJU Int 90:898, 2002. 242. Prasad AS, Cossack ZT: Zinc supplementation and growth in sickle cell
216. Baruchel S, Rees J, Bernstein ML, et al: Relief of sickle cell priapism disease. Ann Intern Med 100:367, 1984.
by hydralazine. Report of a case. Am J Pediatr Hematol Oncol 15:115, 243. Heyman MB, Vichinsky E, Katz R, et al: Growth retardation in sickle-
1993. cell disease treated by nutritional support. Lancet 1:903, 1985.
217. Dahm P, Rao DS, Donatucci CF: Antiandrogens in the treatment of 244. Badaloo AV, Singhal A, Forrester TE, et al: The effect of splenectomy
priapism. Urology 59:138, 2002. for hypersplenism on whole body protein turnover, resting metabolic
218. Levine LA, Guss SP: Gonadotropin-releasing hormone analogues in rate and growth in sickle cell disease. Eur J Clin Nutr 50:672, 1996.
the treatment of sickle cell anemia-associated priapism. J Urol 150:475, 245. Lane PA, Githens JH: Splenic syndrome at mountain altitudes in sickle
1993. cell trait. Its occurrence in nonblack persons. JAMA 253:2251, 1985.
219. Rogers ZR: Priapism in sickle cell disease. Hematol Oncol Clin North 246. Diggs LW: The sickle cell trait in relation to the training and assignment
Am 19:917, viii, 2005. of duties in the armed forces: III. Hyposthenuria, hematuria, sudden
220. Fowler JE, Jr, Koshy M, Strub M, et al: Priapism associated with the death, rhabdomyolysis, and acute tubular necrosis. Aviat Space Environ
sickle cell hemoglobinopathies: prevalence, natural history and sequelae. Med 55:358, 1984.
J Urol 145:65, 1991. 247. Gonzalez-Redondo JM, Kutlar A, Kutlar F, et al: Molecular character-
221. Emerson GG, Lutty GA: Effects of sickle cell disease on the eye: clinical ization of Hb S(C) β-thalassemia in American Blacks. Am J Hematol
features and treatment. Hematol Oncol Clin North Am 19:957, ix, 38:9, 1991.
2005. 248. Christakis J, Vavatsi N, Hassapopoulou H, et al: A comparison of sickle
222. Stevens MC, Padwick M, Serjeant GR: Observations on the natural cell syndromes in northern Greece. Br J Haematol 77:386, 1991.
history of dactylitis in homozygous sickle cell disease. Clin Pediatr 249. Serjeant GR, Sommereux AM, Stevenson M, et al: Comparison of
(Phila) 20:311, 1981. sickle cell-β° thalassemia and homozygous sickle cell disease. Br J
223. Aguilar C, Vichinsky E, Neumayr L: Bone and joint disease in sickle Haematol 41:83, 1979.
cell disease. Hematol Oncol Clin North Am 19:929, viii, 2005. 250. Serjeant GR, Serjeant BE: Comparison of sickle cell-β° thalassemia and
+
224. Hutchinson RM, Merrick MV, White JM: Fat embolism in sickle cell sickle cell-β thalassemia in Black populations. In Cao A, Carcassi U,
disease. J Clin Pathol 26:620, 1973. Rowley PT, editors: Thalassemia: Advances in detection and treatment.
225. Clare A, FitzHenley M, Harris J, et al: Chronic leg ulceration in Birth Defects Original Article Series, New York, 1982, Alan R. Liss, p 233.
homozygous sickle cell disease: the role of venous incompetence. Br J 251. Friedman S, Schwartz E, Ahern E, et al: Variations in globin chain
Haematol 119:567, 2002. synthesis in hereditary persistence of fetal hemoglobin. Br J Haematol
226. Kato GJ, McGowan V, Machado RF, et al: Lactate dehydrogenase as a 32:357, 1976.
biomarker of hemolysis-associated nitric oxide resistance, priapism, leg 252. Dozy AM, Kan YW, Embury SH, et al: Alpha-globin gene organisa-
ulceration, pulmonary hypertension, and death in patients with sickle tion in blacks precludes the severe form of alpha-thalassaemia. Nature
cell disease. Blood 107:2279, 2006. 280:605, 1979.

